BeStock  

BioCryst Pharmaceuticals BCRX

US equityMarket cap rank #2720Drug Manufacturers - Specialty & Generic
$7.22 −$0.10 (-1.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.10 -1.66%
Open$7.26
Prev close$7.32
Day range$7.15 – $7.39
Volume3.85M
Market cap$1.86B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-5.9x
CheapRich

Above its usual level · 70th percentile, 5-year average -19.7x

Price / book-4.9x
CheapRich

Below its usual level · 36th percentile, 5-year average -7.0x

Price / sales2.0x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 6.2x

#2576 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-171x-105x-39x28xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$8.08
Price vs. fair value-10.6%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -4.93 – -6.96 36% (cheaper than usual) –
PE -5.95 12.23 -19.70 70% (pricier than usual) –
PS 2.04 2.77 6.23 0% (cheaper than usual) #2576 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on BCRX.

Sign in to join the discussion.

Scroll to Top